Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions

International Journal of Cancer

Volumn 75, Issue 4, 1998, Pages 529-535

  Sasagawa, Toshiyuki ^a   Yamazaki, Hiroshi ^a   Dong, Yu Zhen ^a   Satake, Shin Ichirou ^b   Tateno, Masaya ^c   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Saiseikai Takaoka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS DNA;

ANTIBODY RESPONSE; ARTICLE; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUNCH BIOPSY; SERODIAGNOSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS PARTICLE; WART VIRUS;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PAPILLOMAVIRIDAE; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032498553     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980209)75:4<529::AID-IJC7>3.0.CO;2-V     Document Type: Article

References (22)

1. BERNARD, H.U., CHAN, S.Y. and MANOS, M.M., Identification and assessment of known and novel human papillomaviruses by polymerase-chain-reaction amplification, restriction-fragment-length polymorphism, nucleotide sequence and phylogenetic algorithms. J. infect. Dis., 170, 1077-1085 (1994).
2. BONFIGLIO, T.A., Uterine cervix. In: R.E. Scully, T.A. Bonfiglio, R.J. Kurman and E.J. Wilkinson (eds.), Histological typing of female genitaltract tumours, pp. 39-54. World Health Organization, Geneva (1994).
3. BOSCH, F.X., MANOS, M., MUÑOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V. KURMAN, R.J. and SHAH, K.V., International Biological Study on Cervical Cancer (IBSCC) study group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. nat. Cancer Inst., 87, 796-802 (1995).
4. CHRISTENSEN, N.D., DILLNER, J., EKLUND, C., CARTER, J.J., WIPF, G.C., REED, C.A., CLADEL, N.M. and GALLOWAY, D.A., Surface conformational and linear epitopes on HPV-16- and HPV-18-virus-like particles as defined by monoclonal antibodies. Virology, 223, 174-184 (1996).
5. CRAWFORD, L., Vaccines against human papillomaviruses and associated tumors. In: G. Barbanti-Brodano (ed.), DNA tumor viruses: oncogenic mechanisms, pp. 157-169, Plenum Press, New York (1995).
6. Du GRUIJL, T.D., BONTKES, H.J., WALBOOMERS, J.M.M., SCHILLER, J.T., STUKART, M.J., GROT, B.S., CHABAUD, M.M.R., REMMINK, A.J., VERHEIJEN, R.H.M., HELMERHORST, T.J.M., MEIJER, C.J.L.M. and SCHEPER, R.J., Immunoglobulin-G responses against human-papillomavirus-type-16-virus-like particles in a prospective non-intervention cohort study of women with cervical intra-epithelial neoplasia. J. nat. Cancer Inst., 89, 630-638 (1997).
7. DONG, Y., SASAGAWA, T., FAN, S., YAMAZAKI, H., SAKAIKE, J., JIANG, A., SONG, L. and INOUE, M., Human papileomavirus, C. trachomatis infections and other risk factors associated with cervical cancer in China. Int. J. clin. Oncol. (1997) (in press).
8. FELDMAN, M., Antibody response in vivo. In: I. Roitt, J. Brostoff and D. Male (eds.), Immunology, 3rd ed., p. 7, 14, Mosby, St. Louis, Baltimore, Boston, Chicago, Philadelphia, Sydney, Toronto (1993).
9. HEINO, P., SKYLDBERG, B., LEHTINEN, M., RANTALA, L., HAGMAR, B., KREIDER, J.W., KIRNBAUER, R. and DILLNER, J., Human-papillomavirus-type-16 capsids expose multiple type-restricted and type-common antigenic epitopes. J. gen Virol., 76, 1141-1153 (1995).
10. Ho, G.Y., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. and ROMNEY, S., Persistent genital human-papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 1365-1367 (1995).
11. KJAER, S.K., VAN DEN BRULE, A.J.C., BOCK, J.E., POLL, P.A., ENGHOLM, G., SHERMAN, M.E., WALBOOMERS, J.M.M. and MEIJER, C.J.L.M., Human papillomavirus - the most significant risk determinant of cervical intra-epithelial neoplasia. Int. J. Cancer, 65, 601-606 (1996).
12. KIRNBAUER, R., HUBBERT, N.L., WHEELER, C.M., BECKER, T.M., LOWY, D.R. and SCHILLER, J.T., A virus-like-particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. nat. Cancer Inst., 86, 474-475 (1994).
13. MATSUKURA, T. and SUGASE, M., Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathological lesions. Int. J. Cancer, 61, 13-22 (1995).
14. NONNENMACHER, B., HUBBERT, N.L., KIRNBAUER, R., SHAH, K.V., MUNOZ, N., BOSCH, F.X., DE SANJOSE, S., VISCIDI, R., LOWY, D.R. and SCHILLER, J.T., Serologic response to human-papillomavirus-type-16(HPV 16) virus-like particles in HPV-16-DNA-positive invasive-cervical-cancer and cervical-intra-epithelial-neoplasia-grade-III patients and controls from Colombia and Spain. J. infect. Dis., 172, 19-24 (1995).
15. PARKIN, D.M., PIANI, P. and FERLAY, J., Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 594-606 (1993).
16. ROOK, G., Immunity to viruses. In: I. Roitt, J. Brostoff and D. Male (eds.), Immunology, 3rd ed., p. 15.3, Mosby, St. Louis, Baltimore, Boston, Chicago, Philadelphia, Sydney, Toronto (1993).
17. SASAGAWA, T., DONG, Y. SAIJOH, K., SATAKE, S., TATENO, M. and INOUE, M., Human papillomavirus infection and risk determinants for squamous intra-epithelial lesion and cervical cancer in Japan. Jap. J. Cancer Res., 88, 376-384 (1997).
18. SASAGAWA, T., INOUE, M., LEHTINEN, M., ZHANG, W., GSCHMEISSNER, S.E., HAJIBAGHERI, M.A., FINCH, J. and CRAWFORD, L., Serological responses to human-papillomavirus-type-6 and -16 virus-like particles in patients with cervical neoplastic lesions. Clin. Diag. Lab. Immunol., 3, 403-410 (1996).
19. SOLOMON, D., The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis. J. Amer. Med. Ass., 262, 931-934 (1989).
20. TINDLE, R.W. and FRAZER, I.H., Human-papillomavirus infection, genital warts and cervical cancer: prospects for prophylactic and therapeutic vaccines. Exp. Opin. Invest. Drugs, 4, 783-797 (1995).
21. WANG, Z., HANSSON, B.C., FORSLUND, O., DILLNER, L., SAPP, M. and SCHILLER, J.T., BJERRE, B. and DILLNER, J., Cervical mucus antibodies against human-papillomavirus-type-16, -18, and -33 capsids in relation to presence of viral DNA. J. clin. Microbiol., 3, 3056-3062 (1996).
22. WIDEROFF, L. and 15 OTHERS, Evaluation of seroreactivity to human-papillomavirus-type-16-virus-like particles in an incident case-control study of cervical neoplasia. J. infect. Dis., 172, 1425-1430 (1995).